4//SEC Filing
Ji Henry 4
Accession 0001193125-25-235241
CIK 0001820190other
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 8:42 AM ET
Size
5.9 KB
Accession
0001193125-25-235241
Insider Transaction Report
Form 4
Ji Henry
DirectorCEO and President
Transactions
- Award
Incentive Stock Option (right to buy)
2025-10-08+120,000→ 120,000 totalExercise: $17.58Exp: 2035-10-08→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Notwithstanding the preceding sentence, the shares of Common Stock subject to the Option will not be exercisable until such date as the Issuer's outstanding indebtedness under the Senior Secured Promissory Note issued by the Issuer to Oramed Pharmaceuticals, Inc. on September 21, 2023 and the Tranche B Senior Secured Convertible Notes issued by the Issuer to each of Oramed Pharmaceuticals, Inc., Nomis Bay Ltd., 3i LP and BPY Limited, has been repaid in full.
Documents
Issuer
Scilex Holding Co
CIK 0001820190
Entity typeother
Related Parties
1- filerCIK 0001470981
Filing Metadata
- Form type
- 4
- Filed
- Oct 8, 8:00 PM ET
- Accepted
- Oct 9, 8:42 AM ET
- Size
- 5.9 KB